Melinda S. Gordon

Hypoxia-Inducible Factor-1-Dependent Repression of E-cadherin in von Hippel-Lindau Tumor Suppressor—Null Renal Cell Carcinoma Mediated by TCF3, ZFHX1A, and ZFHX1B

Melinda S. Gordon · Yearbook of Oncology · 2007 · 348 citations

Medicine, Cancer Biology, Oncology +12

Somatic hypermutation of the B cell receptor genes <i>B29</i> ( <i>Ig</i> β, CD79b) and <i>mb1</i> ( <i>Ig</i> α, CD79a)

Melinda S. Gordon, Cindy M. Kanegai, Jeanette R. Doerr et al. · Proceedings of the National Academy of Sciences · 2003 · 140 citations

Life Sciences, Immunology, Oncology +16

Patterned CpG Methylation of Silenced B Cell Gene Promoters in Classical Hodgkin Lymphoma-derived and Primary Effusion Lymphoma Cell Lines

Jeanette R. Doerr, Cindy S. Malone, Francesca Fike et al. · Journal of Molecular Biology · 2005 · 58 citations

Life Sciences, Genetics, Molecular Biology +17

Inhibition of heat shock protein 90 (Hsp90) with the novel agent IPI-504 in metastatic GIST following failure of tyrosine kinase inhibitors (TKIs) or other sarcomas: Clinical results from phase I trial

A Wagner, Jeffrey A. Morgan, Rashmi Chugh et al. · Journal of Clinical Oncology · 2008 · 49 citations

Medicine, Oncology, Pharmacology +15

Antimyeloma effects of arsenic trioxide are enhanced by melphalan, bortezomib and ascorbic acid

Richard A. Campbell, Eric Sanchez, Jeffrey A. Steinberg et al. · British Journal of Haematology · 2007 · 43 citations

Medicine, Oncology, Pharmacology +13